Research Developments in Psoriatic Arthritis

Target Audience
This activity was developed for rheumatologists, primary care physicians and other healthcare providers who manage patients with rheumatoid arthritis.

Program Overview
The latest research related to the treatment of patients with psoriatic arthritis is often first made public at the American College of Rheumatology (ACR) annual meeting. In this CME activity, Dr. Roy Fleischmann discusses three posters presented at ACR Convergence 2020. Dr. Fleischmann summarizes the methods and results of each posters and provides his own thoughts as to the importance of the research findings and implications for clinical practice in the treatment of patients with psoriatic arthritis.

Content Areas
Guselkumab
Upadacitinib
Ustekinumab
Learning Objectives
Upon completion of this activity, participants should be better able to:

Summarize the latest research developments in the treatment of psoriatic arthritis
Describe how new data and recommendations can impact clinical practices to improve care
Incorporate evidence-based research into clinical practice